Willebrand - PDFSEARCH.IO - Document Search Engine

Willebrand
Results: 314

#	Item
1	en77 Original Article Improved Handling of Synonymous SNOMED CT Concepts used in HL7 Version 3 by the Example of the Von Willebrand Disease Add to Reading List Source URL: www.ejbi.org Language: English - Date: 2017-06-28 11:48:09
2	Supplementary Materials Supplementary Figure 1. Ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex (PDB code: 1U0N) as an example of a non-interacting protein pair. Red – Von Willebrand factor (1 Add to Reading List Source URL: mips.helmholtz-muenchen.de Language: English - Date: 2013-10-04 12:05:00
3	Article pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor Jochen P. Mu¨ller,1,* Achim Lo¨f,1 Salome´ Mielke,1 Tobias Obser,2 Linda K. Bruetzel,1 Willem Vanderlinden,1,3 J Add to Reading List Source URL: www.biophysik.physik.uni-muenchen.de Language: English - Date: 2016-07-28 04:23:33 Chemistry Equilibrium chemistry Acid dissociation constant PH Buffer solution Isoelectric point Atomic-force microscopy WeibelPalade body
4	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites Add to Reading List Source URL: www.cslbehring.at Language: English - Date: 2013-11-18 05:52:30 Blood Coagulation system Anatomy CSL Behring Von Willebrand disease Factor VIII Coagulation CSL Limited Hereditary angioedema Haemophilia Factor IX Factor VII
5	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites Add to Reading List Source URL: www.cslbehring.at Language: English - Date: 2013-11-18 05:52:29 Blood Coagulation system Haemophilia Medicine Peripheral membrane proteins CSL Behring Recombinant proteins CSL Limited Factor VII Haemophilia B Von Willebrand disease Coagulation
6	IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic Add to Reading List Source URL: www.sanquin.nl Language: English - Date: 2015-11-10 06:17:54 Medicine Anatomy Blood Coagulation system Acquired hemolytic anemia Blood disorders Rare diseases Hemolytic-uremic syndrome Nephrology Thrombotic thrombocytopenic purpura Thrombotic microangiopathy Von Willebrand factor
7	CrossMark_Color_flat+click Add to Reading List Source URL: www.biophysik.physik.uni-muenchen.de Language: English - Date: 2016-01-25 04:04:04 Coagulation system Von Willebrand factor WeibelPalade body Von Willebrand disease Integrin Calcium in biology Coagulation ADAMTS13 Atomic-force microscopy Platelet Dimer Actin
8	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR Add to Reading List Source URL: labeling.cslbehring.com Language: English - Date: 2016-05-26 14:29:43 Blood Medicine Clinical medicine RTT Von Willebrand disease Cryoprecipitate Recombinant factor VIIa CSL Behring Haemophilia International unit Turoctocog alfa
9	Major Therapeutic Products Marketed by CSL Behring Bleeding Disorders Coagulation therapies are used to treat bleeding disorders such as hemophilia, Von Willebrand Disease and more.  Add to Reading List Source URL: www.cslbehring.com Language: English - Date: 2016-03-15 19:08:23
10	UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A • Add to Reading List Source URL: www.nektar.com Language: English - Date: 2015-07-30 13:12:07 Blood Coagulation system Biology Recombinant proteins Baxalta Von Willebrand disease Haemophilia Factor VIII PEGylation Baxter International Factor VII Recombinant factor VIIa

UPDATE